会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Method for identifying the analytical transitional cross-sections of a rigid transport element
    • 用于识别刚性传输元件的分析过渡横截面的方法
    • US08301417B2
    • 2012-10-30
    • US12269747
    • 2008-11-12
    • Weigang Hu
    • Weigang Hu
    • G06F17/50G06G7/48
    • G06F17/50G06F2217/34
    • According to a preferred embodiment, a method for identifying the analytical transitional cross-sections of a rigid transport element is disclosed. The method includes providing a 3D model of a rigid transport element, a list of total edges from the 3D model, a list of total faces from the 3D model, and a list of connecting edges from the 3D model, identifying all edges from said list of total edges which have connectivity with any edge in the list of connecting edges and are part of a cross-section, placing the identified edges into a list of cross-section edges, and identifying the analytical cross-section that lies on the plane defined by the edges in said list of cross-section edges.
    • 根据优选实施例,公开了用于识别刚性传送元件的分析过渡横截面的方法。 该方法包括提供刚性传输元件的3D模型,来自3D模型的总边缘列表,来自3D模型的总面部列表以及来自3D模型的连接边缘列表,从所述列表中识别所有边缘 的总边缘与连接边缘列表中的任何边缘具有连接性,并且是横截面的一部分,将识别的边缘放置在横截面边缘的列表中,并且识别位于定义的平面上的分析横截面 通过所述横截面边缘列表中的边缘。
    • 3. 发明申请
    • Method for Identifying the Analytical Transitional Cross-sections of a Rigid Transport Element
    • 识别刚性运输元件分析过渡截面的​​方法
    • US20100121611A1
    • 2010-05-13
    • US12269747
    • 2008-11-12
    • Weigang Hu
    • Weigang Hu
    • G06F17/50
    • G06F17/50G06F2217/34
    • According to a preferred embodiment, a method for identifying the analytical transitional cross-sections of a rigid transport element is disclosed. The method includes providing a 3D model of a rigid transport element, a list of total edges from the 3D model, a list of total faces from the 3D model, and a list of connecting edges from the 3D model, identifying all edges from said list of total edges which have connectivity with any edge in the list of connecting edges and are part of a cross-section, placing the identified edges into a list of cross-section edges, and identifying the analytical cross-section that lies on the plane defined by the edges in said list of cross-section edges.
    • 根据优选实施例,公开了用于识别刚性传送元件的分析过渡横截面的方法。 该方法包括提供刚性传输元件的3D模型,来自3D模型的总边缘列表,来自3D模型的总面部列表以及来自3D模型的连接边缘列表,从所述列表中识别所有边缘 的总边缘与连接边缘列表中的任何边缘具有连接性,并且是横截面的一部分,将识别的边缘放置在横截面边缘的列表中,并且识别位于定义的平面上的分析横截面 通过所述横截面边缘列表中的边缘。
    • 5. 发明授权
    • Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to Venezuelan equine encephalitis virus
    • 针对委内瑞兰马脑炎病毒的链霉抗生物素蛋白结合肽标记的单链可变片段抗体的遗传工程
    • US07527796B2
    • 2009-05-05
    • US10784305
    • 2004-02-24
    • R. Elaine FultonLeslie P. NagataAzhar Z. AlviWeigang Hu
    • R. Elaine FultonLeslie P. NagataAzhar Z. AlviWeigang Hu
    • A61K39/00A61K39/42
    • C07K16/1081C07K2317/622C07K2319/22
    • A recombinant gene encoding a single-chain variable fragment (scFv) antibody against Venezuelan equine encephalitis virus (VEE) being cloned into a prokaryotic T7 RNA polymerase-regulated expression vector was disclosed. A streptavidin-binding peptide (SBP) sequence fused to a 6His tag is then attached downstream to the scFv gene. The recombinant fusion protein is expressed in bacteria and then purified by immobilized metal affinity chromatography. ELISA and Western blotting results revealed that the fusion protein not only retained VEE antigen binding and specificity properties similar to those of its parent native monoclonal antibody, but also possessed streptavidin-binding activity. This discovery obviates the need for chemical biotinylation of antibodies and the risk associated with antibody denaturation and provides a stable and reproducible reagent for rapid and efficient immunoassay of VEE.
    • 公开了克隆到原核T7RNA聚合酶调节表达载体中的编码针对委内瑞兰马脑炎病毒(VEE)的单链可变片段(scFv)抗体的重组基因。 然后将与6His标签融合的链霉抗生物素蛋白结合肽(SBP)序列连接到scFv基因的下游。 重组融合蛋白在细菌中表达,然后通过固定化金属亲和层析纯化。 ELISA和Western印迹结果表明,融合蛋白不仅保留了VEE抗原结合和特异性,与其母体天然单克隆抗体相似,而且具有链霉抗生物素蛋白结合活性。 这一发现消除了对抗体的化学生物素化和与抗体变性相关的风险的需要,并且提供用于快速和有效的VEE免疫测定的稳定且可重现的试剂。